Advertisement

Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson’s disease

  • Loredana Raciti
  • Alessandra Nicoletti
  • Giovanni Mostile
  • Roberta Bonomo
  • Valeria Dibilio
  • Giulia Donzuso
  • Giorgia Sciacca
  • Calogero Edoardo Cicero
  • Antonina Luca
  • Mario ZappiaEmail author
Brief Communication
  • 2 Downloads

Abstract

Background

In a precedent paper, we validated part IV of the Unified Parkinson’s Disease Rating Scale (UPDRS) for detecting motor fluctuations in Parkinson’s Disease (PD) patients using a 12-h Waking-Day Motor Assessment (WDMA) as gold standard, showing a high sensitivity (> 80%) and a lower specificity (< 45%). The aim of this study was to validate the Movement Disorder Society-UPDRS (MDS-UPDRS) part IV, especially items 4.3 and 4.5, using the same methodology.

Methods

PD patients attending the Movement Disorders Clinic at the University Hospital in Catania were consecutively enrolled in the study. A diurnal WDMA was performed to detect motor fluctuations. At each time interval, the motor impairment was evaluated using the motor section of the MDS-UPDRS. Presence or absence of motor fluctuations and the type of motor fluctuation were assessed by four blinded expert raters in movement disorders, by evaluating the graphical representations of the WDMA. We evaluated sensitivity and specificity together with 95% Confidence Interval (CI) of items 4.3 and 4.5, using WDMA as gold standard.

Results

We estimated for item 4.3 of the MDS-UPDRS a sensitivity of 74.3% (95% CI 56.7–87.5) and a specificity of 70.6% (95% CI 44–89.7), while for item 4.5, a sensitivity of 67.9% (95% CI 47.6–84.1) and a specificity of 66.7% (95% CI 44.7–84.4).

Conclusions

The present showed a higher specificity level for MDS-UPDRS with respect to the UPDRS, while a slightly lower sensitivity mainly for predictable OFF.

Keywords

MDS-UPDRS validation 12-h waking-day motor assessment (WDMA) Motor fluctuations Wearing-off Dyskinesia 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study has been approved by the local ethics committee and it has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Supplementary material

10072_2019_3745_MOESM1_ESM.doc (54 kb)
ESM 1 (DOC 54 kb)

References

  1. 1.
    Chase TN, Mouradian MM, Engber TM (1993) Motor response complications and the function of striatal efferent systems. Neurology 43:S23–S26Google Scholar
  2. 2.
    Ondo WG, Hunter C, Ferrara JM, Mostile G (2012) Apomorphine injections: predictors of initial common adverse events and long term tolerability. Parkinsonism Relat Disord 18:619–622CrossRefGoogle Scholar
  3. 3.
    Contrafatto D, Mostile G, Nicoletti A, Raciti L, Luca A, Dibilio V, Lanzafame S, Distefano A, Drago F, Zappia M (2011) Single photon emission computed tomography striatal asymmetry index may predict dopaminergic responsiveness in Parkinson disease. Clin Neuropharmacol 34:71–73Google Scholar
  4. 4.
    Fahn S, Elton RL, the Members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson's disease. Macmillan, London, pp 153–163Google Scholar
  5. 5.
    Raciti L, Nicoletti A, Mostile G, Bonomo R, Contrafatto D, Dibilio V, Luca A, Sciacca G, Cicero CE, Vasta R, Zappia M (2016) Validation of the UPDRS section IV for detection of motor fluctuations in Parkinson's disease. Parkinsonism Relat Disord 27:98–101CrossRefGoogle Scholar
  6. 6.
    Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, PA LW, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRefGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  • Loredana Raciti
    • 1
  • Alessandra Nicoletti
    • 1
  • Giovanni Mostile
    • 1
  • Roberta Bonomo
    • 1
  • Valeria Dibilio
    • 1
  • Giulia Donzuso
    • 1
  • Giorgia Sciacca
    • 1
  • Calogero Edoardo Cicero
    • 1
  • Antonina Luca
    • 1
  • Mario Zappia
    • 1
    Email author
  1. 1.Department “G.F. Ingrassia”, Section of NeurosciencesUniversity of CataniaCataniaItaly

Personalised recommendations